Maternal care for other rhesus isoimmunization, third trimester (fetus 2)
ICD-10 O36.0932 is a billable code used to indicate a diagnosis of maternal care for other rhesus isoimmunization, third trimester (fetus 2).
Maternal care for rhesus isoimmunization involves the management of a condition where the mother's immune system produces antibodies against the Rh factor present in the fetus's blood. This condition can lead to hemolytic disease of the newborn, which may result in fetal anemia, jaundice, and other complications. In the third trimester, careful monitoring is crucial as the fetus may experience growth restriction due to anemia or other related issues. Maternal care includes regular ultrasounds to assess fetal growth, Doppler studies to evaluate blood flow, and possibly intrauterine transfusions if severe anemia is detected. The management plan may also involve administering Rh immunoglobulin (RhoGAM) to prevent further isoimmunization in future pregnancies. Close collaboration with maternal-fetal medicine specialists is often necessary to ensure optimal outcomes for both mother and fetus.
Detailed records of maternal health, fetal assessments, and interventions.
Management of fetal growth restriction, monitoring for fetal distress, and planning for delivery.
Ensure accurate coding for multiple fetuses and associated complications.
Comprehensive documentation of high-risk factors, ultrasound findings, and treatment plans.
Complex cases involving fetal anemia, intrauterine transfusions, and multidisciplinary care.
Focus on high-risk management protocols and detailed fetal monitoring.
Used for monitoring fetal growth and well-being in cases of isoimmunization.
Document findings, including fetal size and any signs of distress.
Obstetricians should ensure accurate coding for ultrasound procedures.
Accurate coding of O36.0932 is crucial for ensuring appropriate management of high-risk pregnancies, facilitating proper reimbursement, and providing data for quality improvement initiatives in maternal-fetal care.
